AllianceBernstein’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Buy |
65,290
+9,420
| +17% | +$34.9K | ﹤0.01% | 3004 |
|
|
2025
Q1 | $180K | Hold |
55,870
| – | – | ﹤0.01% | 2949 |
|
|
2024
Q4 | $311K | Hold |
55,870
| – | – | ﹤0.01% | 2849 |
|
|
2024
Q3 | $604K | Hold |
55,870
| – | – | ﹤0.01% | 2570 |
|
|
2024
Q2 | $1.17M | Buy |
55,870
+19,320
| +53% | +$406K | ﹤0.01% | 2217 |
|
|
2024
Q1 | $1.16M | Buy |
36,550
+6,380
| +21% | +$203K | ﹤0.01% | 2178 |
|
|
2023
Q4 | $611K | Sell |
30,170
-53,100
| -64% | -$1.08M | ﹤0.01% | 2511 |
|
|
2023
Q3 | $1.06M | Sell |
83,270
-5,370
| -6% | -$68.4K | ﹤0.01% | 2200 |
|
|
2023
Q2 | $1.6M | Buy |
88,640
+71,540
| +418% | +$1.29M | ﹤0.01% | 2032 |
|
|
2023
Q1 | $294K | Hold |
17,100
| – | – | ﹤0.01% | 2777 |
|
|
2022
Q4 | $380K | Buy |
+17,100
| New | +$380K | ﹤0.01% | 2775 |
|